"","Blank 1","Frequency","Blank 2","Frequency","Blank 3","Frequency"
"2","unable",2,"unwilling to discontinue use of prohibited",4,"                                                ",3
"1","subject is unable",1,"unwilling to discontinue predefined prohibited",2,"listed in the protocol for 4 weeks of a drug whichever is longer prior to visit 1 and for the duration of the study                          ",2
"3","patient is unable",1,"nonprescription",1,"for at least 7 days prior to the first dose of study drug and for the duration of the study                               ",1
"4","expansion cohort only patient is unable",1,"",NA,"for at least 28 days prior to the first dose of topotecan / pazopanib and for the duration of the study                              ",1
"5","",1,"",NA,"",NA
"7","subjects who are unable",1,"",NA,"",NA
